Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05202158
Other study ID # RIRS2022
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 15, 2022
Est. completion date September 1, 2022

Study information

Verified date July 2022
Source Ankara Training and Research Hospital
Contact Ali Kaan Yildiz
Phone +90 554 773 16 96
Email alikaanyildiz@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this prospective randomised controlled study, investigators aims to evaluate the effect of 80 mg gentamicin added to 3 liters of irrigation fluid on stone free rate, intraoperative and postoperative complications during RIRS for kidney stones.


Description:

Current advances in endoscopic technology for the upper urinary tract have expanded the diagnosis and treatment options for kidney stones. Retrograde intrarenal surgery (RIRS), defined as the use of effective lithotripters such as flexible ureteroscopes (fURSs) and holmium:yttrium aluminum garnet (holmium:YAG) lasers for intrarenal pelvic diseases, is a safe and effective, versatile and minimally invasive procedure for the kidney. . Current guidelines for the treatment of kidney stones recommend RIRS first for stones <2 cm. and RIRS as one of the first two options for stones >2 cm.. In studies dealing with kidney stones larger than 2 cm, the RIRS showed a cumulative stone-free success of 91%, but a complication rate of 8.6%. Of these, 44% were found to be ≥ Clavien 3 complications. In kidney stone endourological treatments, stone culture was found to be more effective in predicting complications than midstream urine culture. Even if the preoperative midstream urine culture is sterile, complication rates increase if there is bacterial growth in the stone culture in kidney stone surgery. Therefore, although complication rates are generally low, several concerns have arisen. In our study, the investigators aims to evaluate the effect of 80 mg gentamicin added to 3 liters of irrigation fluid on stone free rate and complications during RIRS for kidney stones.


Recruitment information / eligibility

Status Recruiting
Enrollment 76
Est. completion date September 1, 2022
Est. primary completion date August 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - <2 cm. kidney stones Exclusion Criteria: - Ureteral stricture - Active urinary tract infection - Coagulopathies

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Addition of gentamicin to irrigation fluid during RIRS
During the RIRS, the access sheath is placed first for security. Then, the stone in the kidney is detected with flexible URS and fragmented with a holmium laser. In this group of patients, 80 mg of gentamicin will be added to 3 liters of irrigation fluid while the stone is being fragmented.
Only irrigation fluid during RIRS
During the RIRS, the access sheath is placed first for security. Then, the stone in the kidney is detected with flexible URS and fragmented with a holmium laser. In this group of patients, only irrigation fluid will be used while the stone is fragmented.

Locations

Country Name City State
Turkey Ankara Training and Research Hospital Ankara Altindag

Sponsors (1)

Lead Sponsor Collaborator
Ankara Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Türk C, Petrík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2016 Mar;69(3):468-74. doi: 10.1016/j.eururo.2015.07.040. Epub 2015 Aug 28. Review. — View Citation

Walton-Diaz A, Vinay JI, Barahona J, Daels P, González M, Hidalgo JP, Palma C, Díaz P, Domenech A, Valenzuela R, Marchant F. Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study. In — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of postoperative complications Rate of patients who had an complication after the operation One year
See also
  Status Clinical Trial Phase
Recruiting NCT04495699 - Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
Recruiting NCT04559321 - Holmium Vs Trilogy Kidney Stones GUY's 1-2 Phase 3
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Recruiting NCT06138327 - A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria Phase 1
Completed NCT03872843 - Opioid Free Management After Ureteroscopy Phase 4
Recruiting NCT04997668 - Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis N/A
Active, not recruiting NCT04333745 - Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers N/A
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Recruiting NCT04389853 - Mini-PNCL vs fURS in Management of Nephrolithiasis N/A
Recruiting NCT05334979 - Oxalate and Citrate N/A
Recruiting NCT05591716 - Evaluation of the Efficacy and Safety of Unimodal Bilateral Flexible Ureteroscopy. N/A
Recruiting NCT06209931 - RIRS With Tip Flexible Pressure-controlling Ureteral Access Sheath Versus Mini PCNLfor Kidney Stones
Withdrawn NCT04545528 - The Impact of Nutritional Service in the Stone Clinic on the Patient Urine Collection Results
Completed NCT05714423 - Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery N/A
Recruiting NCT03281928 - Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling N/A
Recruiting NCT04835922 - Comparison of Efficacy of Intercostal Nerve Block vs Peritract Infiltration With 0.25% Bupivacaine in PCNL N/A
Recruiting NCT03257306 - Magnetic Ureteral Stent Symptoms - a Comparison to Standard Ureteral Stent as Perceived By the Patient (MAGUSS) N/A
Not yet recruiting NCT05504512 - Percutaneous Nephroscopic Treatment of Parapelvic Cysts
Recruiting NCT06306222 - Thulium Fiber Laser vs. Holmium:YAG Laser for the Ureteroscopic Treatment of Patients With Urinary Stone Disease N/A
Not yet recruiting NCT04606758 - Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease N/A